NCT05477056View on ClinicalTrials.gov

Quality Improvement PrecivityAD Clinician Survey (QUIP I)

CompletedOBSERVATIONAL
Enrollment

366

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

October 6, 2022

Study Completion Date

October 6, 2022

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentDementiaCognitive Decline
Interventions
OTHER

PrecivityAD blood test

Clinician Survey post receipt of PrecivityAD blood test result

Trial Locations (1)

63110

C2N Diagnostics, St Louis

Sponsors

Lead Sponsor

C2N Diagnostics
All Listed Sponsors
lead

C2N Diagnostics

INDUSTRY

NCT05477056 - Quality Improvement PrecivityAD Clinician Survey (QUIP I) | Biotech Hunter | Biotech Hunter